Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity

Research output: Contribution to journalJournal articleResearchpeer-review

  • Pauline Morigny
  • Marianne Houssier
  • Aline Mairal
  • Claire Ghilain
  • Etienne Mouisel
  • Fadila Benhamed
  • Bernard Masri
  • Emeline Recazens
  • Pierre-Damien Denechaud
  • Geneviève Tavernier
  • Sylvie Caspar-Bauguil
  • Sam Virtue
  • Veronika Sramkova
  • Laurent Monbrun
  • Anne Mazars
  • Madjid Zanoun
  • Sandra Guilmeau
  • Valentin Barquissau
  • Diane Beuzelin
  • Sophie Bonnel
  • And 27 others
  • Marie Marques
  • Boris Monge-Roffarello
  • Corinne Lefort
  • Barbara Fielding
  • Thierry Sulpice
  • Arne Astrup
  • Bernard Payrastre
  • Justine Bertrand-Michel
  • Emmanuelle Meugnier
  • Laetitia Ligat
  • Frédéric Lopez
  • Hervé Guillou
  • Charlotte Ling
  • Cecilia Holm
  • Remi Rabasa-Lhoret
  • Wim H M Saris
  • Vladimir Stich
  • Peter Arner
  • Mikael Rydén
  • Cedric Moro
  • Nathalie Viguerie
  • Matthew Harms
  • Stefan Hallén
  • Antonio Vidal-Puig
  • Hubert Vidal
  • Catherine Postic
  • Dominique Langin
Impaired adipose tissue insulin signalling is a critical feature of insulin resistance. Here we identify a pathway linking the lipolytic enzyme hormone-sensitive lipase (HSL) to insulin action via the glucose-responsive transcription factor ChREBP and its target, the fatty acid elongase ELOVL6. Genetic inhibition of HSL in human adipocytes and mouse adipose tissue results in enhanced insulin sensitivity and induction of ELOVL6. ELOVL6 promotes an increase in phospholipid oleic acid, which modifies plasma membrane fluidity and enhances insulin signalling. HSL deficiency–mediated effects are suppressed by gene silencing of ChREBP and ELOVL6. Mechanistically, physical interaction between HSL, independent of lipase activity, and the isoform activated by glucose metabolism ChREBPα impairs ChREBPα translocation into the nucleus and induction of ChREBPβ, the isoform with high transcriptional activity that is strongly associated with whole-body insulin sensitivity. Targeting the HSL–ChREBP interaction may allow therapeutic strategies for the restoration of insulin sensitivity.
Original languageEnglish
JournalNature Metabolism
Issue number1
Pages (from-to)133-146
Number of pages14
Publication statusPublished - 2019

    Research areas

  • Faculty of Science - Insulin resistance, Hormone-sensitive lipase, HSL, Glucose-responsive transcription factor, ChREBP, Fatty acid elongase, ELOVL6, HSL-ChREBP interaction, Therapeutic strategies, Insulin sensitivity

Number of downloads are based on statistics from Google Scholar and

No data available

ID: 209516937